U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07044557) titled 'MeDex: No Perioperative Dexamethasone in Brain Metastases' on June 23.
Brief Summary: Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Brain Metastases
Intervention:
OTHER: Withholding perioperative Dexamethasone
Patients will not receive perioperative Dex before, during, and up to 3 weeks after surgery.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Louisville
Information provided by (Responsible Party): Akshitkumar MIstry, University of Louisville
Published by HT Digital Content S...